Skip to content

GAV 2.0 FX212TRecalls & reported problems

Aesculap AG · GAV 2.0 VALVE 5/30 · Class 2 · Implant

All models of GAV 2.0 (16)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
6
Deaths reported
0
Injuries reported
3
Recalls naming it
0

Summary

The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 04041906500023), received between Oct 4, 2023 and Aug 31, 2026 — classified as 3 injuries, 3 malfunctions.

The most frequently reported specific device problem is “Infusion or Flow Problem” (4 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 1 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 1 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 1 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 1 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 1 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Infusion or Flow Problem4
  • Obstruction of Flow2
  • Insufficient Device Problem Information1

Patient problems

  • Hydrocephalus5
  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 31, 2026Obstruction of Flow

    It was reported that a GAV 2.0 (#FX212T) was implanted on (b)(6) 2026. According to the complainant, the valve caused an underdrainage. The patient underwent a revision procedure on (b)(6) 2026. The sample was returned for examination.

    Patient problems: Hydrocephalus

    MAUDE report 50515559 ↗
  • InjuryOct 27, 2025Obstruction of Flow; Obstruction of Flow

    IT WAS REPORTED THAT A GAV 2.0 (#FX212T) WAS IMPLANTED DURING A PROCEDURE PERFORMED ON 09/09/2025. ACCORDING TO THE COMPLAINANT, THE SHUNT SYSTEM CAUSED AN UNDERDRAINAGE. THE PATIENT UNDERWENT A REVISION PROCEDURE ON (B)(6) 2025. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THE REVISION PROCEDURE. THE COMPLAINED DEVICE WAS RETURNED TO THE MANUFACTURER FOR EVALUATION.

    Patient problems: Hydrocephalus

    MAUDE report 23390831 ↗
  • MalfunctionApr 21, 2025Infusion or Flow Problem; Insufficient Device Problem Information; Infusion or Flow Problem; Insufficient Device Problem Information

    IT WAS REPORTED THAT AN GAV 2.0 SHUNTSYSTEM (#FX212T) WAS TO BE IMPLANTED DURING A PROCEDURE PERFORMED ON (B)(6) 2025 . ACCORDING TO THE COMPLAINANT, THE SHUNT SYSTEM CAUSED PROBLEMS IN THE PREOPERATIVE TESTING AND WASN'T USED. NO PATIENT INVOLVEMENT OR HARM WSA REPORTED. THE COMPLAINED DEVICE WAS NOT YET RETURNED TO THE MANUFACTURER FOR EVALUATION.

    Patient problems: Hydrocephalus

    MAUDE report 21873651 ↗
  • MalfunctionAug 7, 2024Infusion or Flow Problem; Infusion or Flow Problem

    IT WAS REPORTED THAT A GAV 2.0 (#) WAS TESTED PREOPERATIVELY AND DID NOT HAVE THE CORRECT PRESSURE LEVEL, THE VALVE WAS UNDERDRAINED. NO PATIENT INVOLVEMENT.

    Patient problems: Hydrocephalus

    MAUDE report 19930468 ↗
  • MalfunctionMar 4, 2024Infusion or Flow Problem; Infusion or Flow Problem

    IT WAS REPORTED THAT ONE OF THE GAV 2.0 (#FX212T) DIDN'T WORK PROPERLY AS IT IS FAULTY. AT PRE-IMPLANTATION CHECK NO FLOW THROUGH VALVE. THEN AFTER FLUSHING FLOW BUT AT MEASURE 15CM H2O AS OPPOSED TO 5CM H2O. THE VALVE WAS NOT IMPLANTED AND A DIFFERNET WAS USED AND FUNCTIONED NORMALLY. NO PATIENT HARM WAS REPORTED. THE SAMPLE WILL BE RETURNED FOR EVALUATION TO THE MANUFACTURER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18829375 ↗
  • InjuryOct 4, 2023Infusion or Flow Problem; Infusion or Flow Problem

    IT WAS REPORTED THAT A GAV 2.0 (#FX212T) WAS IMPLANTED DURING A PROCEDURE PERFORMED ON (B)(6) 2023. ACCORDING TO THE COMPLAINANT, THE VALVE WAS BELIEVED TO BE OPERATED IN UNDERDRAINAGE. THE PATIENT UNDERWENT A REVISION PROCEDURE. THE COMPLAINANT DEVICE WAS RETURNED TO THE MANUFACTURER FOR EVALUATION. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THE REVISION PROCEDURE. AGE: 2 YEARS. WEIGHT: 12 KILOGRAMS. GENDER: MALE.

    Patient problems: Hydrocephalus

    MAUDE report 17871889 ↗

Other Shunt, central nervous system and components devices

All Shunt, central nervous system and components devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page